Annual Report

Overview

The report highlights Bukwang's successful 2024 launch of Latuda® as a new treatment option for Korean patients. It reports consolidated revenues of KRW 160.1 billion and operating income of KRW 1.6 billion, marking a return to operating profitability. The ESG section describes oversight by a Board of Directors ESG Committee and identifies ISO 14001 and ISO 45001 certifications.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services